What You Should Know:– Sanofi has agreed to acquire Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), for $25.00 per share in cash, representing an equity value of…
Source: hitconsultant.net – Read more
The Pennsylvania Attorney General’s Office Updates Ransomware Attack Incident
On September 17, the Pennsylvania Attorney General’s Office posted the following update to a ransomware attack it initially disclosed on August 11. HARRISBURG — The
